DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Lacroix A, Gu F, Gallardo W. et al.
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.
Lancet Diabetes Endocrinol 2018;
6: 17-26
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.